Olodaterol Hydrochloride

• CAT Number: I008443
• CAS Number: 869477-96-3
• Molecular Formula: C21H27ClN2O5
• Molecular Weight: 422.91
• Purity: 98%
• Synonyms: Olodaterol hydrochloride; Olodaterol HCl; BI-1744; BI 1744; BI1744; Olodaterol; Striverdi;(R)-6-hydroxy-8-(1-hydroxy-2-((1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO
• Appearance: Off-white solid
• Storage: 0 - 4 °C for short term, or -20 °C for long term
• IUPAC Name: 6-hydroxy-8-[(1R)-1-hydroxy-2-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]ethyl]-4H-1,4-benzoxazin-3-one;hydrochloride
• InChI: InChI=1S/C21H26N2O5.ClH/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17;/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26);1H/t18-;/m0./s1
• InChIKey: KCEHVJZZIGJAAW-FERBBOLQSA-N
• SMILES: CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=CC(=CC3=C2OCC(=O)N3)O)O.Cl

Olodaterol Hydrochloride(CAT: I008443) is a long-acting beta-2 adrenergic agonist (LABA) specifically developed for the management of chronic obstructive pulmonary disease (COPD). By activating beta-2 receptors in the airway smooth muscles, it induces prolonged bronchodilation, enhancing airflow and alleviating symptoms such as breathlessness. Administered via once-daily inhalation, Olodaterol Hydrochloride provides sustained symptom control, improving pulmonary function and patient quality of life. Its high selectivity for beta-2 receptors minimizes cardiovascular side effects, making it a safe and effective option for long-term COPD management. This compound is widely studied in respiratory research for its role in advancing therapies for obstructive airway diseases.